Pharma

Your Article Summary

See Latest Articles

Medtronic Clinical Trial Evaluating the Newest Radiofrequency Ablation Tools for Atrial Fibrillation Completes Enrollment
Medtronic, 05/18/09

Medtronic, Inc. announced completion of enrollment in the TTOP-AF clinical trial. The study is evaluating the use of the latest radiofrequency ablation technology, the Medtronic Ablation Frontiers Cardiac Ablation System, for the treatment of continuous atrial fibrillation. A leading advancement from currently available RF ablation tools, the system is comprised of a RF generator and three anatomically shaped mapping and ablation catheters that target three areas of the heart for AF treatment. The system is approved for use in Europe and is under investigational use in the United States.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Data Presented at San Antonio Breast Cancer Symposium Demonstrate Treatment with Denosumab is Superior to the Standard of Care
Amgen, 12/10/09

Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
Repligen, 12/10/09

Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors
Journal of Clinical Oncology, 12/10/09

 See all of Drug Trials

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

Roche Introduces New Automated Clinical Laboratory System for CE-Marked Testing of Human Papillomavirus, Chlamydia and N. gonorrhoeae
Roche, 12/10/09

EHRs Certified Under 2011 Criteria
HealthDataManagement, 12/10/09

Phase III Data Showed Rituxan Plus Chemotherapy Improved Survival in Patients With Most Common Form of Adult Leukemia
Genentech, 12/08/09

 See all of Medical Devices/Products